RBx-9841

N/A

Report date: 2024/01/10 15:11:51
NME

Base Information

Drug NameRBx-9841
Drug Alias NameRBx-9841
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M3 agonists
TargetsMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsUrinary Incontinence
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRanbaxy Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRanbaxy Laboratories
Active IndicationsN/A
Inactive IndicationsUrinary Incontinence

Other Information

ATC CodeN/A
Related LinksN/A